The developers of OpenFold3 have released an early version of the tool, which they hope will one day perform on par with DeepMind’s protein-structure model.

Harvard and Northwestern researchers combine AI and physics to design unstable proteins that comprise the dark proteome.

New research from the University of Wisconsin–Madison reveals that dysfunction in a protein essential to maintaining ...

Ribosomes are the cell's protein factories, which read the genetic code and assemble the proteins that every organism needs ...

AI adoption is accelerating fast across Southeast Asia, and Google is helping the region turn this momentum into practical ...

Mr. Marcus is a founder of two A.I. companies and the author of “Taming Silicon Valley: How We Can Ensure That AI Works for Us.” The biggest artificial intelligence companies are racing to be the ...

She described AI not merely as a technological tool, but as a powerful catalyst for transformation that could reshape ...

Google's Ruth Porat believes that AI has transformative potential and could significantly reshape industries and healthcare.

Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft patents that satisfy written description and enablement requirements.

State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules.